|Molecular cloning of a human homologue of Drosophila heterochromatin protein HP1 using anti-centromere autoantibodies with anti-chromo specificity.
|Interaction between an integral protein of the nuclear envelope inner membrane and human chromodomain proteins homologous to Drosophila HP1.
|Domain-specific interactions of human HP1-type chromodomain proteins and inner nuclear membrane protein LBR.
|Localization and phosphorylation of HP1 proteins during the cell cycle in mammalian cells.
|Methylation of histone H3 lysine 9 creates a binding site for HP1 proteins.
|Common properties of nuclear protein SP100 and TIF1alpha chromatin factor: role of SUMO modification.
|Complete sequencing and characterization of 21,243 full-length human cDNAs.
|The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).
|A conserved Mis12 centromere complex is linked to heterochromatic HP1 and outer kinetochore protein Zwint-1.
|Dissociation of heterochromatin protein 1 from lamin B receptor induced by human polyomavirus agnoprotein: role in nuclear egress of viral particles.
|The mammalian heterochromatin protein 1 binds diverse nuclear proteins through a common motif that targets the chromoshadow domain.
|In vivo HP1 targeting causes large-scale chromatin condensation and enhanced histone lysine methylation.
|Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.
|A quantitative atlas of mitotic phosphorylation.
|Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle.
|Physical and functional interaction between heterochromatin protein 1alpha and the RNA-binding protein heterogeneous nuclear ribonucleoprotein U.
|Human BAHD1 promotes heterochromatic gene silencing.
|Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.
|The metastasis efficiency modifier ribosomal RNA processing 1 homolog B (RRP1B) is a chromatin-associated factor.
|JAK2 phosphorylates histone H3Y41 and excludes HP1alpha from chromatin.
|ASXL1 represses retinoic acid receptor-mediated transcription through associating with HP1 and LSD1.
|The middle region of an HP1-binding protein, HP1-BP74, associates with linker DNA at the entry/exit site of nucleosomal DNA.
|Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.
|Lamin A rod domain mutants target heterochromatin protein 1alpha and beta for proteasomal degradation by activation of F-box protein, FBXW10.
|Human POGZ modulates dissociation of HP1alpha from mitotic chromosome arms through Aurora B activation.
|Quantitative interaction proteomics and genome-wide profiling of epigenetic histone marks and their readers.
|Recognition and specificity determinants of the human cbx chromodomains.
|Initial characterization of the human central proteome.
|Mitotic centromeric targeting of HP1 and its binding to Sgo1 are dispensable for sister-chromatid cohesion in human cells.
|System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation.
|N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.
|Toward a comprehensive characterization of a human cancer cell phosphoproteome.
|An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.
|Uncovering global SUMOylation signaling networks in a site-specific manner.
|System-wide analysis of SUMOylation dynamics in response to replication stress reveals novel small ubiquitin-like modified target proteins and acceptor lysines relevant for genome stability.
|SUMO-2 orchestrates chromatin modifiers in response to DNA damage.
|A novel role of PRR14 in the regulation of skeletal myogenesis.
|Site-specific mapping of the human SUMO proteome reveals co-modification with phosphorylation.